Pre-Seed, Seed
$250K – $3.0M
16+ companies
5 partners
Investment Thesis
Dedicated to early-stage biotech with cutting-edge innovations in oncology and cell therapy solutions, focusing on niche applications.
Meet the Team
Emily Nguyen
Founding GP
Industry Focus
Invests In
Does Not Invest In
Portfolio Companies (16)
Other
BioRegen Therapeutics
TumorTarget Biotech
AIRNA Therapeutics
"Discovered via firm_website (high confidence)"
Pioneering the discovery and development of RNA editing therapeutics for patients with rare and common diseases.
AXONIS Therapeutics
"Discovered via firm_website (high confidence)"
Advancing breakthroughs in neuroscience to develop first-in-class precision therapies for neurological disorders.
BioGraph55
"Discovered via firm_website (high confidence)"
Developing bispecific antibodies against a novel subset of immunosuppressive cells to treat resistant cancers.
IpiNovyx Bio
"Discovered via firm_website (high confidence)"
Develops next-generation, ultra-selective proteasome inhibitors for oncology and autoimmune disease applications.
miRecule
"Discovered via firm_website (high confidence)"
Developing RNA-based therapeutics for cancer and muscular dystrophy.
Modifi Bio
"Discovered via firm_website (high confidence)"
Creating a new class of oral medicines that selectively kill cancer cells via direct DNA modification.
Nionyx Bio
"Discovered via firm_website (high confidence)"
Developing transformative gene therapies for patients with severe kidney diseases.
Ochre Bio
"Discovered via firm_website (high confidence)"
Developing novel RNA-based therapeutics for chronic liver diseases.
Browse More Investors
Frequently Asked Questions
See if Pathway Bioventures is a match for your startup
Upload your pitch deck to see how well you match with Pathway Bioventures and 200+ other VC firms.